On the contrary, overexpressed HDAC9 may inhibit EMT by decreasing the nuclear accumulation of β-catenin and the acetylation of β-catenin at Lys-49 in non-serous ovarian cancer (Figure 7). The gene discussed is HDAC9; the disease is ovarian serous adenocarcinoma.